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Abstract
Background—Host pathogen relationships can be classified as allopatric, when the pathogens 
originated from separate, non-overlapping geographic areas from the host; or sympatric, when 
host and pathogen shared a common ancestral geographic location. It remains unclear if host–
pathogen relationships, as defined by phylogenetic lineage, influence clinical outcome. We sought 
to examine the association between allopatric and sympatric phylogenetic Mycobacterium 
tuberculosis lineages and pulmonary impairment after tuberculosis (PIAT).
Methods—Pulmonary function tests were performed on patients 16 years of age and older who 
had received ≥20 weeks of treatment for culture-confirmed M. tuberculosis complex. Forced 
Expiratory Volume in 1 min (FEV1) ≥80%, Forced Vital Capacity (FVC) ≥80% and FEV1/FVC 
>70% of predicted were considered normal. Other results defined pulmonary impairment. 
Spoligotype and 12-locus mycobacterial interspersed repetitive units-variable number of tandem 
repeats (MIRU-VNTR) were used to assign phylogenetic lineage. PIAT severity was compared 
between host–pathogen relationships which were defined by geography and ethnic population. We 
used multivariate logistic regression modeling to calculate adjusted odds ratios (aOR) between 
phylogenetic lineage and PIAT.
Results—Self-reported continental ancestry was correlated with Mycobacterium. tuberculosis 
lineage (p < 0.001). In multivariate analyses adjusting for phylogenetic lineage, age and smoking, 
the overall aOR for subjects with allopatric host–pathogen relationships and PIAT was 1.8 (95% 
confidence interval [CI]: 1.1, 2.9) compared to sympatric relationships. Smoking >30 pack-years 
was also associated with PIAT (aOR: 3.2; 95% CI: 1.5, 7.2) relative to smoking <1 pack-years.
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Conclusions—PIAT frequency and severity varies by host–pathogen relationship and heavy 
cigarette consumption, but not phylogenetic lineage alone. Patients who had disease resulting from 
allopatric–host–pathogen relationship were more likely to have PIAT than patients with disease 
from sympatric–host–pathogen relationship infection. Further study of this association may 
identify ways that treatment and preventive efforts can be tailored to specific lineages and racial/
ethnic populations.
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1. Background
Approximately 2 million persons die annually from tuberculosis (TB) and among those that 
survive, at least half will experience pulmonary impairment after TB (PIAT) that can be 
debilitating (Pasipanodya et al., 2007, 2010; Vecino et al., 2011; World Health 
Organization, 2010). Previous studies have described host, pathogen, environmental, and 
lifestyle factors associated with outcomes after TB exposure, after latent Mycobacterium 
tuberculosis infection, or after TB disease (Blaser and Kirschner, 2007; Caws et al., 2008; 
Coscolla and Gagneux, 2010; Kato-Maeda et al., 2001; Malik and Godfrey-Faussett, 2005; 
Pasipanodya et al., 2012b; van Crevel et al., 2009). Clinical studies have not demonstrated 
clear relationships between host genetic susceptibility factors, M. tuberculosis lineages, and 
TB outcomes (Caws et al., 2008; van Crevel et al., 2009).
PIAT may vary by race/ethnicity (Pasipanodya et al., 2010). Non-Hispanic Whites suffer 
more frequent and severe PIAT relative to other racial groups. Increased risk for PIAT 
remained after controlling for cigarette smoking, healthcare access, treatment, and 
socioeconomic status, suggesting that other factors contributed to PIAT (Pasipanodya et al., 
2010). However, pathogen factors including M. tuberculosis phylogenetic differences were 
not included in these studies. Evidence suggests hosts and pathogens co-evolution and some 
mycobacterial species, including M. tuberculosis, might adapt to certain human populations 
(Blaser and Kirschner, 2007; Gagneux, 2012). While the theory of co-evolution remains 
unproven, molecular characterization of the M. tuberculosis complex has allowed genotypes 
to be grouped into distinct lineages in a way that correlates with ethnic populations and 
geography (Blaser and Kirschner, 2007; Coscolla and Gagneux, 2010; Gagneux, 2012). This 
host–pathogen relationship can be classified as sympatric, when host and pathogen shared a 
common ancestral geographic location or allopatric, when the pathogens originated from 
different, non-overlapping geographic areas from the host (Blaser and Kirschner, 2007).
Our study aims to examine whether co-evolution, as determined by host–pathogen 
relationships, is associated with clinical outcomes in patients treated for pulmonary TB. We 
hypothesized that persons with pulmonary TB disease caused by sympatric genotypes are 
less likely to have pulmonary impairment (because of evolutionary coadaptation) as 
compared to persons with allopatric genotypes.
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2. Materials and methods
2.2. Patients and setting
This was a prospective study of patients 16 years of age and older treated for culture-
confirmed M. tuberculosis at Tarrant County Public Health (TCPH) during July 2005–
December 2010. TCPH has jurisdiction as the health authority for Tarrant County, Texas, an 
urban county with a population of 1,789,900 persons (Tarrant County Public Health, 2010). 
TCPH provides subsidized treatment to all persons with TB within this jurisdiction, using 
universal direct observation of therapy (DOT) delivered to the patient’s preferred location 
(Tarrant County Public Health, 2010; Weis et al., 1994). Standard treatments for TB and 
TB/HIV recommended by the American Thoracic Society (ATS) and U.S. Centers for 
Diseases and Prevention Control (CDC) were used for all patients (Blumberg et al., 2003). 
Patients with at least three consecutive negative cultures, and who had completed at least 20 
weeks of DOT (i.e., non-infectious) were eligible for enrolment. Patients with exclusive 
extra-pulmonary tuberculosis (i.e., disease outside of the lung parenchyma) or those treated 
for, or cured of, drug resistant TB were excluded from this study. Ever smokers were 
patients who gave a history of current or past cigarette smoking. Lifetime cigarette exposure 
was estimated using pack-years. Similarly, exposure to solid fuel smoke (i.e., biomass fuel 
exposure) and duration of biomass fuel exposure was compared between groups. Body mass 
index (BMI) was calculated using patient height and weight at the time of enrolment.
The Institutional Review Board of the University of North Texas Health Science Center at 
Fort Worth approved the study. All subjects gave written informed consent.
2.3. Pulmonary function testing
Spirometric pulmonary function tests (PFTs) were performed on each patient. Spirometry 
was conducted according to ATS guidelines for maneuver, technique, and quality control 
using the Spirotouch® device (Spirotouch®, Spirometry System 086578; Spacelabs Burdick; 
Deerfield, WI) (Miller et al., 2005). Patients with a history of bronchodilator use received 
nebulized albuterol 15 min before the test. Results were considered consistent if there was 
≤5% variation between results on three separate tests (Miller et al., 2005; Cocchiarella and 
Andersson, 2000). Once consistency was attained, the best of three results determined 
pulmonary impairment grading.
An interpretive algorithm from the American Medical Association (AMA), which is 
consistent with the global initiative for chronic obstructive lung disease (GOLD) 
classification of chronic obstructive pulmonary disease (COPD), was used to categorize the 
degree of pulmonary impairment associated with non-normal PFT values (Miller et al., 
2005; Cocchiarella and Andersson, 2000). Forced Expiratory Volume in 1 min (FEV1) 
≥80%, Forced Vital Capacity (FVC) ≥80% and FEV1/FVC >70% of predicted were 
considered normal. Other results defined pulmonary impairment. Impairment was 
categorized as none, mild (if FEV1 or FVC was >60% but <80%), moderate (if FEV1 or 
FVC was 41–59%) or severe (if FEV1 or FVC was ≤40%). Analyses compared any 
impairment versus no impairment and examined stratification by grade of impairment.
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Mycobacterial isolates were characterized using a standardized protocol for spacer 
oligotyping (spoligotyping) and 12-locus mycobacterial interspersed repetitive units-variable 
number of tandem repeats (MIRU-VNTR) as part of routine public health program activities 
at the TCPH through CDC’s National TB Genotyping Service (Centers for Diseases Control 
and Prevention, 2005; Ghosh et al., 2012).
2.4.1. Genotypic definitions—Four major phylogenetic lineages for M. tuberculosis 
[East African Indian, East Asian (i.e., Beijing strains), Euro-American, Indo-Oceanic], along 
with speciation of Mycobacterium africanum, were assigned using a set of rules correlating 
spoligotype with lineages defined by large sequence polymorphisms (LSP) (Click et al., 
2012b; Supply et al., 2006). In cases that did not meet the full requirement for phylogenetic 
lineage assignment based on spoligotype, 12-locus MIRU-VNTR results was used in 
addition to spoligotype to assign lineage, as described elsewhere (Click et al., 2012b; 
Shabbeer et al., 2012). We excluded patients with M. africanum or Mycobacterium bovis 
isolates.
2.5. Race/ethnicity and ancestral origins
Race was based on a self-reported continental ancestry (i.e., African/Black, European/
Caucasian, Asian, Pacific Islander, and Native American) established during interview (Lee 
et al., 2008; Lin and Kelsey, 2000; Risch and Ziv, 2002; Rosenberg et al., 2002; 
Zhivotovsky et al., 2003). Africans denote persons whose primary ancestry is sub-Saharan 
Africa including African-American and Afro-Caribbean. Caucasians includes those with 
ancestry in Europe and West Asia including the Middle East and North Africa. Hispanics, 
who represent a recently admixed group between Native Americans, Caucasian and Africans 
(Baena et al., 2002; Mountain and Risch, 2004; Risch and Ziv, 2002; Zhivotovsky et al., 
2003), were considered a separate and distinct group.
2.6. Host–pathogen relationships
A conservative, and more ancient, phylogeographic distribution of M. tuberculosis lineages 
that precedes recent human global population migrations, first described by Gagneux (2012), 
were used in this study. Thus, a sympatric host–pathogen relationship was considered if the 
lineage of the M. tuberculosis isolated from the patient was similar to the designated 
ancestral geographic origin of the patient. If the person and the lineage of the isolate 
originated from non-overlapping geographic locale, the host–pathogen relation was defined 
as allopatric. For example: East Asians infected with the East Asian lineage, European/
Caucasians infected with Euro-American lineage, and South East Asians or East Africans 
infected with the East African Indian lineage were considered sympatric.
2.7. Statistical analysis
PIAT, the primary outcome variable, was dichotomized by combining mild, moderate and 
severe impairment versus no impairment. Multivariate logistic regression models were built 
to examine PIAT and host–pathogen relationships. Smoking and age have been are 
associated with greater pulmonary impairment and, therefore, were included in multivariate 
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models for all patients enrolled in study regardless of statistical significance (Boelaert et al., 
2003; Davies et al., 2006; Kerstjens et al., 1997). Additional potential confounders included 
in the ‘full’ or initial model were sex, body mass index, biomass exposure and lineage. We 
built the final model by eliminating non-significant independent variables with p-values 
<0.1 and using the backward likelihood ratio test procedure at each elimination step. The 
Hosmer–Lemeshow goodness-of-fit was used to examine and compare the models. Separate 
within lineage multivariate logistic regression analyses were also examined. In view of the 
small size, particularly for certain lineage groups, to gain power we also dichotomized 
lineage as ancient versus modern to examine if modern lineages were more ‘aggressive/
destructive’ in allopatric relationships. Pearson’s chi-square, symmetric lambda statistic, or 
Fisher’s exact tests were used to compare proportions wherever appropriate. Analysis of 
variance (ANOVA) or Kruskall–Wallis tests were used to compare continuous variables. 
The Mantel–Haenszel test was used to examine the trend across pulmonary impairment 
levels.
3. Results
3.1. Study participants and phylogenetic lineages
Phylogenetic lineage of the M. tuberculosis-complex isolates collected was determined for 
317 (95%) of 332 patients with valid pulmonary function tests, including 311 (98%) M. 
tuberculosis isolates, 5 (2%) M. bovis isolates and 1 (<1%) M. africanum isolate. Of the 311 
M. tuberculosis isolates assigned to lineages, 182 (59%) belonged to the Euro-American 
lineage, 72 (23%) to the East Asian lineage, 6 (2%) to the East African Indian lineage and 
51 (16%) to the Indo-Oceanic lineage (Table 1).
Table 1 shows the demographic and clinical characteristics of all 311 patients enrolled in the 
study, comprising of 184 (59%) sympatric and 127 (41%) allopatric host–pathogen 
relationships. Males were significantly less likely to be in allopatric host–pathogen 
relationships while U.S.-born persons were more likely; crude odds ratios (OR) were 0.5 
(95% confidence interval [CI] 0.3, 0.8) and 4.5 (95% CI 2.8, 7.3), respectively. Body mass 
index, age, and exposure to cigarette smoke and biomass fuels; factors known to influence 
pulmonary function test results, were not significantly different between host–pathogen 
relationships.
Among all patients, a significant correlation between self-reported continental ancestry and 
M. tuberculosis lineage was observed (Lambda = 0.24; p < 0.01). This correlation remained 
significant when self-reported Hispanics were excluded from analysis (Lambda = 0.26; p < 
0.01). Euro-American lineage was the most geographically distributed lineage and was 
identified in persons from all regions of the world. Eighty percent of the Euro-American 
isolates were collected from patients born in the United States, Mexico, or Europe. The 
majority (114/182) of patients with Euro-American lineage isolates identified as European/
Caucasian ancestry either directly (i.e., self-reported race/ethnicity) or indirectly (i.e., 
country of birth) suggesting geographical association between this lineage and infected 
ethnic populations. However, the majority (67%) of East Asian isolates were collected from 
patients who did not self-identify as Asian and were born in countries outside East Asia. 
Hence, relative to the Indo-Oceanic, the East Asian lineage was more likely to be found in 
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allopatric relationship (crude OR: 5.2; 95% CI: 2.3, 11.4). The East African Indian and the 
Indo-Oceanic lineages were predominantly sympatric, 6/6 (100%) and 38/51 (75%), 
respectively (Table 1).
3.2. Phylogenetic lineages, host–pathogenic relationships and PIAT
Overall, nearly half (154/311) of the patients had pulmonary impairment of varying levels of 
severity (Table 1; Fig. 1). There was no significant association between lineage and 
pulmonary impairment found in univariate (p = 0.13) or multivariate analysis (p = 0.73). As 
shown in Tables 2 and 3 the associations between host-pathogen relationships and PIAT 
were variable, but significantly associated among all enrolled subjects and within the East 
Asian, Euro-American and Indo-Oceanic lineages (Table 3). The adjusted OR for PIAT was 
2.1 (95% CI 1.1, 4.1) higher for patients with disease resulting from allopatric versus 
sympatric infection among patients with Euro-America strains and 6.0 (95% CI 1.5, 23.9) 
among those with the East Asian lineage. Disease resulting from allopatric infection among 
patients with Indo-Oceanic strains were inversely associated with PIAT, adjusted OR 0.14 
(95% CI 0.02, 0.91) (Table 3). A second multivariate logistic regression model that 
controlled for age and smoking volume and was restricted to patients with allopatric 
relationships; relative to the Indo-Oceanic lineage, the East Asian lineage was associated 
with PIAT and Euro-American lineage was not. The aOR was 5.4 (95% C.I. 1.1, 27.0). On 
the contrary, both lineages (i.e. East Asian and Euro-American) were not associated with 
PIAT using an exact multivariate model restricted to patients with sympatric relationships 
(Data not shown).
Out of twelve self-identified Asians infected with allopatric Euro-American lineages, 58% 
(7/12) were impaired and the degree of impairment was moderate-to-severe in 5 (71%). 
Conversely, among the 27 Asians infected with sympatric East-Asian lineages 41% (11/ 27) 
were impaired (p < 0.02). Among those impaired only 1 (9%) had moderate-to-severe 
impairment (p < 0.02). Thus Asians with disease due to allopatric Euro-American lineages 
were more likely to have pulmonary impairment and it was more severe than subjects with 
disease due to the sympatric East Asian strains. Similar to Asians, European/Caucasians 
with disease from infection with allopatric lineages had more frequent and more severe 
PIAT. Among 19 self-identified European/Caucasians with disease from infection with 
allopatric East-Asian lineages, 84% (16/19) were impaired, and in 8 (50%) the impairment 
was moderate-to-severe. Among the 45 European/Caucasians infected with sympatric Euro-
American lineages, 64% (29/45) were impaired (p < 0.05). Among those impaired, 11 (38%) 
had moderate-to-severe impairment (p < 0.05). Of the 14 European/Caucasian non-smokers, 
60% (6/10) infected with sympatric versus 100% (4/4) with allopatric were impaired (p = 
0.25). Small numbers and high smoking prevalence of lifetime exposure among European/
Caucasians precluded attaining statistical significance in univariate analysis (Table 3). 
Nonetheless, combined (Tables 3 and 4) these results show that the variable distribution of 
PIAT may be due to host–pathogen relationships.
Lastly, in backward stepwise regression modeling, only smoking and host–pathogen 
relationships where significantly associated with pulmonary impairment. A potential dose-
response trend between smoking and pulmonary impairment was observed (p = 0.02); 
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however, only those who smoked >30 pack-years significantly more likely to have PIAT 
(aOR: 2.6; 95% CI: 1.1, 6.2). Patients with allopatric host–pathogen relationships had nearly 
double the odds of PIAT (aOR: 1.8; 95% CI: 1.1, 2.9) compared to patients with sympatric 
host–pathogen relationships.
4. Discussion
Patients with tuberculosis often have very different clinical outcomes. There are a number of 
patient factors that influence the clinical presentation and outcome (Perez-Velez and Marais, 
2012; Blumberg et al., 2003). However, factors specific to M. tuberculosis and the host 
pathogen relationship are unclear. We show, for the first time, that patients with pulmonary 
TB who had disease from organisms with allopatric host–pathogen relationships were more 
likely to have PIAT. Patients with TB disease from East Asian lineages, who also had 
allopatric host–pathogen relationships, had six-times greater odds of having PIAT when 
compared to patients who had sympatric host–pathogen relationships. Similarly among 
patients with TB disease from Euro-American lineages with allopatric host–pathogen 
relationships had approximately twice the odds of having PIAT when compared to patients 
with sympatric host–pathogen relationships. Overall patients with allopatric host–pathogen 
relations had greater PIAT; however, there was one exception. Patients infected with the 
Indo-Oceanic lineage, allopatric host–pathogen relationships were inversely associated with 
PIAT (Table 3). M. tuberculosis lineage alone was not significantly associated with PIAT. 
Thus, patients who had TB disease resulting from allopatric relationships were more likely 
to have PIAT than patients with disease from sympatric relationship.
Additionally, PIAT was more likely to be moderate-to-severe in patients with disease from 
allopatric host–pathogen relationships than sympatric. Patients with disease with a 
sympatric host– pathogen relationship were more likely to have no impairment. Previously, 
we showed that PIAT is more frequent and severe in certain risk groups and racial/ethnic 
populations and also demonstrated that PIAT could be life-long (Pasipanodya et al., 2010, 
2012b; Vecino et al., 2011). In these studies, self-reported non-Hispanic white was 
associated with PIAT, while various measures of socio-economic status were not. Analysis 
of data of self-identified European/Caucasians and Asians infected with either Euro-
American or East-Asian lineages demonstrated that an increased frequency of allopatric 
host–pathogen relationships explained the racial/ethnic differences in PIAT distribution that 
we reported earlier. Thus, the Whites were more likely to be infected with East-Asian 
genotypes which were allopatric and associated with severity of PIAT (Pasipanodya et al., 
2012b).
Our finding on the effect of allopatric sympatric relationship and PIAT, rather than lineage 
per se, adds to the understanding of the disproportionate racial/ethnic distribution noted by 
others across the TB disease spectrum (Stead et al., 1990; Long and Jablon, 1955; Crowle 
and Elkins, 1990; Pasipanodya et al., 2012b). These data contribute to difference in 
pulmonary impairment among TB survivors. Previously described racial/ethnic differences 
were limited to: susceptibility to infection, progression to disease after infection, and 
mortality after TB disease (Stead et al., 1990; Long and Jablon, 1955; Crowle and Elkins, 
1990). In a study of long-term care patients in the United States, Stead and others concluded 
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that Blacks were twice as likely to become infected compared to White patients (Stead et al., 
1990). These findings were consistent with an earlier study of U.S. soldiers, which revealed 
a higher incidence of progressive primary tuberculosis after infection among Blacks (4.2%) 
than among Non-Hispanic Whites (2.8%) under comparable environmental conditions 
(Long and Jablon, 1955). Crowle and Elkins demonstrated that macrophages inoculated with 
the same M. tuberculosis strain from Blacks were more ‘permissive’ of tuberculosis 
infection as compared to macrophages collected from Whites (Crowle and Elkins, 1990). In 
all three studies, pathogen genotypes were not identified; however, it is likely that Euro-
American lineages were prevalent among the US population (Stead, 2001). Nonetheless, 
these data support the notion that under comparable conditions, TB outcomes after infection 
or treatment can be affected by host immune response genes; many of these genes can be 
segregated according continental ancestry (Baena et al., 2002; Zhivotovsky et al., 2003). We 
suspect that polymorphic gene variants responsible for TB immune function or those 
involved in xenobiotic metabolism, may differ significantly between racial/continental 
ancestries (Gumbo et al., 2007; Pasipanodya et al., 2012a;), and thus potentially contribute 
to PIAT. These findings suggest that difference in TB outcomes between ethnic/
geographically defined populations groups might have a biological as well as evolutionary 
basis.
Among subjects with East Asian TB lineages (Beijing strains), persons with allopatric host–
pathogen relationships had six times greater odds of having PIAT compared to those with 
sympatric ones (Table 3). This finding could be partly explained in terms of immunogenicity 
and the particular lineage strain ability to evade host innate immune system. We hypothesize 
that both emergent properties are acquired over time in the fight for survival between host 
and pathogen. Interestingly, some East Asian lineage genotypes, such as HN878, W4 and 
W10 genotypes, have been shown to possess an intact polyketide synthase (pks 1/15) gene 
involved in the production of phenolic glycolipid (PGL) (Caws et al., 2008; Parwati et al., 
2010). PGL which has been identified in other Euro-American strains, has been linked to 
hypervirulence phenotypes in laboratory studies that used macrophages and animal models 
(Coscolla and Gagneux, 2010; Malik and Godfrey-Faussett, 2005). Furthermore, East Asian 
isolates have been associated with more severe cavitary disease (Cowley et al., 2008; 
Parwati et al., 2010; van Crevel et al., 2009). Combined, our data provide evidence to 
demonstrate that ‘modern’ lineages particularly East Asian and Euro-America strains 
evolved non-lethal but aggressive/destructive properties in the lungs which enhanced 
intergenerational propagation. The fact that PIAT was more likely to be encountered and 
severe in allopatric rather than across all populations suggests more recent acquisition of 
this property.
An unexpected finding was the protective effect of allopatric relationship against PIAT 
among patients infected with “ancient” Indo-Oceanic lineages. These findings are consistent 
with several prior observations (Mitchison et al., 1960; Goren et al., 1974; Portevin et al., 
2011; Krishnan et al., 2011). M. tuberculosis from southern India, the geographic area 
associated Indo-Oceanic lineages, were shown more than 50 years ago to be less virulent in 
guinea pigs than those collect in the United Kingdom strains (Mitchison et al., 1960). We 
speculate that aggressive/destructive lung damage with which we used PFT as a measure 
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might not be an appropriate measure for virulent among “ancient” strains such as the Ino-
Oceanic lineage. Regardless, our data adds to the growing evidence that virulence and host 
immune response vary considerably between hosts and among different M. tuberculosis 
lineages and should be considered in design of better TB vaccines (Adams et al., 2011; 
Brosch et al., 2002; Cowley et al., 2008; Domenech et al., 2005; Homolka et al., 2010; 
Krishnan et al., 2011; Lamichhane et al., 2005; Parwati et al., 2010; Portevin et al., 2011).
In the United States, spoligotyping and MIRU-VNTR are routinely performed as part of 
national surveillance (Ghosh et al., 2012). Our data suggest that mycobacterial genotype 
combined with patients’ continental ancestry may allow clinicians and TB programs to 
identify those at highest risk for PIAT. Indeed, there is an association between phylogenetic 
lineage and clinical presentation and time-to-culture conversion in patients receiving 
standard anti-TB therapy (Click et al., 2012b,a; Nahid et al., 2010). There are known inter-
ethnic differences in the allele frequencies of enzymes responsible for metabolizing TB 
drugs that contributes to variable drug response (Pasipanodya et al., 2012a). Further study of 
these associations may identify appropriate treatments that can be tailored to specific 
lineages.
In our cohort, there were two variables independently associated with PIAT in multivariate 
analysis: cigarette smoking and allopatric host–pathogen relationships. Our data showed 
that patients smoking >30 pack-years were three times as likely to be associated with PIAT 
as compared to patients with smoking <1 pack-years after adjusting for lineage and age. This 
finding was expected. Smoking is well established to cause decreased pulmonary function 
(Boelaert et al., 2003; Davies et al., 2006; Kerstjens et al., 1997). Both biomass smoke and 
cigarette smoke are believed to induce functional and morphological changes in host 
alveolar macrophages thereby weakening macrophages through sustained alveolar 
inflammation, and facilitating M. tuberculosis persistence (Boelaert et al., 2003; Davies et 
al., 2006). Education about the role of cigarette smoking, its relationship to PIAT, and its 
potential for worsening PIAT should be part of TB treatment.
The study has several limitations. First, race/ethnicity is a social construct that varies with 
time, geography, and has limited taxonomic significance in biology; despite several studies 
showing that genetic clusters correspond closely with groups that self-identify by race/
ethnicity or continental ancestry (Lee et al., 2008; Lin and Kelsey, 2000; Mountain and 
Risch, 2004; Risch and Ziv, 2002; Rosenberg et al., 2002; Zhivotovsky et al., 2003). Indeed, 
several human population studies have shown that genetic differentiation is greatest when 
populations are defined based on continental ancestry, and that self-description of ancestry is 
adequately discriminatory (Lin and Kelsey, 2000; Rosenberg et al., 2002; Zhivotovsky et al., 
2003). Second, admixture among racial/ethnic groups might add misclassification bias. Even 
though mixed race/ethnicity was rare among persons who self-identified European/
Caucasian ancestry, Asian or Pacific Islanders, the Hispanic and African American 
population in the United States has a heterogeneous ethnic ancestry comprising of Native 
American Indians, European and African origins. Thus, these findings are important in 
generating hypotheses for additional genome-wide association studies that examine human 
immunologic markers more strongly associated with area of geographic origin. Third, 
spirometry is a simple, inexpensive and noninvasive tool used widely to measure pulmonary 
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functional impairment; however, it is not disease specific, difficult to interpret and subject to 
misclassification bias. Moreover, TB has been known to cause both obstructive and 
restrictive pulmonary impairment. The distribution of either impairment pattern between 
populations is affected by comorbid conditions, environmental conditions as well as several 
other factors not examined in this study. As such, we may have underestimated mildly to 
moderately restrictive disease among patients, as spirometry does not assess total lung 
capacity (Miller et al., 2005; Cocchiarella and Andersson, 2000). Finally, even though we 
have demonstrated significant variation of pulmonary impairment between allopatric versus 
sympatric host–pathogen groups among treated TB patients, it remains to be determined 
how much of this variation can be attributed to initial racial/ethnic population difference 
prior to TB. Nevertheless, as pulmonary function has been shown to predict premature 
death, these findings can be used in future genome-wide studies to identify actual host and 
pathogen genes associated with PIAT.
5. Conclusion
Lineages per se were not associated with PIAT; however, the sample size was not sufficient 
to state this for all lineages and patient groups. Allopatric host–pathogen relationships and 
certain life-style risk factors were associated with variable odds for pulmonary impairment 
among geographically defined ethnic populations. We concluded that allopatric host–
pathogen relationships explained the disproportionate distribution of PIAT by race/ethnicity 
that we previously reported. The cross-sectional nature of the analysis did not make it 
possible to determine proportion of variation attributable to population difference in 
pulmonary function which is known to segregate by continental ancestry. Further study of 
this association may identify ways that treatment and preventive efforts can be tailored to 
specific lineages and race/ethnic populations to decrease the risk of PIAT.
Acknowledgements
This work was made possible by the cooperation of the Tarrant County Public Health Department and the 
University of North Texas Health Science Center at Fort Worth, as well as both the U.S. Centers for Disease 
Control and Prevention. This research did not receive direct funding from these or other sources; however, the 
Tuberculosis Epidemiologic Studies Consortium and the Tuberculosis Trials Consortium of the CDC provided 
salary support for Drs. Fernandez, Miller, Pasipanodya, Vecino, and Weis, and Ms. Drewyer, although neither 
consortium directly funded this study nor had any role in study design, data collection, data analysis, data 
interpretation, nor writing this report. We thank Drs. Juliana Grant, Michael Iademarco, Phil LoBue, Eugene 
McCray, and Tom Navin for their thoughtful review and helpful comments to the manuscript.
References
Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, et al. Drug tolerance in replicating 
mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 2011; 145:39–53. 
[PubMed: 21376383] 
Baena A, Leung JY, Sullivan AD, et al. TNF-alpha promoter single nucleotide polymorphisms are 
markers of human ancestry. Gene. Immun. 2002; 3(8):482–487.
Blaser MJ, Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature. 2007; 
449(7164):843–849. [PubMed: 17943121] 
Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease 
Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. 
Respir. Crit. Care Med. 2003; 167(4):603–662. [PubMed: 12588714] 
Pasipanodya et al. Page 10













Boelaert JR, Gomes MS, Gordeuk VR. Smoking, iron, and tuberculosis. Lancet. 2003; 362(9391):
1243–1244. [PubMed: 14568761] 
Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, et al. A new evolutionary scenario for 
the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U.S.A. 2002; 99:3684–3689. 
[PubMed: 11891304] 
Caws M, Thwaites G, Dunstan S, et al. The influence of host and bacterial genotype on the 
development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008; 
4(3):e1000034. [PubMed: 18369480] 
Centers for Diseases Control and Prevention (CDC). New CDC program for rapid genotyping of 
mycobacterium tuberculosis isolates. MMWR Morb. Mortal. Wkly. Rep. 2005; 54(2):47. [PubMed: 
16177693] 
Click ES, Winston CA, Oeltman JE, Moonan PK, Cowan KS, Mac Kenzie WR. Association between 
Mycobacterium tuberculosis lineage and time to sputum culture conversion. Am. J. Respir. Crit. 
Care Med. 2012a; 185:A3311.
Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium 
tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin. Infect. Dis. 2012b; 54(2):
211–219. [PubMed: 22198989] 
Cocchiarella, L.; Andersson, GBJ. The Respiratory System. In: Cocchiarella, L.; Andersson, GBJ., 
editors. Guides to the Evaluation of Permanent Impairment. 5th ed.. Chicago: AMA Press; 2000. 
Coscolla M, Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity? Drug 
Discov. Today Dis. Mech. 2010; 7(1):e43–e59. [PubMed: 21076640] 
Cowley D, Govender D, February B, et al. Recent and rapid emergence of W-Beijing strains of 
Mycobacterium tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 2008; 47(10):1252–
1259. [PubMed: 18834315] 
Crowle AJ, Elkins N. Relative permissiveness of macrophages from black and white people for 
virulent tubercle bacilli. Infect. Immun. 1990; 58(3):632–638. [PubMed: 2106489] 
Davies PD, Yew WW, Ganguly D, et al. Smoking and tuberculosis: the epidemiological association 
and immunopathogenesis. Trans. R. Soc. Trop. Med. Hyg. 2006; 100(4):291–298. [PubMed: 
16325875] 
Domenech P, Reed MB, Barry CE 3rd. Contribution of the Mycobacterium tuberculosis MmpL protein 
family to virulence and drug resistance. Infect. Immun. 2005; 73:3492–3501. [PubMed: 
15908378] 
Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos. Trans. R. Soc. Lond. B Biol. 
Sci. 2012; 367(1590):850. [PubMed: 22312052] 
Ghosh S, Moonan PK, Cowan L, Grant J, Kammerer S, Navin TR. Tuberculosis genotyping 
information management system: enhancing tuberculosis surveillance in the United States. Infect. 
Genet. Evol. 2012; 12(4):782–788. [PubMed: 22044522] 
Goren MB, Brokl O, Schaefer WB. Lipids of putative relevance to virulence in Mycobacterium 
tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect. Immun. 1974; 
9:150–158. [PubMed: 4271720] 
Gumbo T, Louie A, Lui W, Brown D, Ambrose PG, Bhavnani SM, Drusano GL. Isoniazid bacterial 
activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics ro 
predict efficacy in different ethnic populations. Antimcrob. Agents Chemother. 2007; 51(7):2329–
2336.
Homolka S, Niemann S, Russell DG, Rohde KH. Functional genetic diversity among Mycobacterium 
tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific 
transcriptomes during intracellular survival. PLoS Pathog. 2010; 6:e1000988. [PubMed: 
20628579] 
Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM. The nature and consequence of genetic 
variability within Mycobacterium tuberculosis. J. Clin. Invest. 2001; 107(5):533–537. [PubMed: 
11238552] 
Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, 
figures, and fallacies. Thorax. 1997; 52(9):820–827. [PubMed: 9371217] 
Pasipanodya et al. Page 11













Krishnan N, Malaga W, Constant P, Caws M, Tran TH, et al. Mycobacterium tuberculosis lineage 
influences innate immune response and virulence and is associated with distinct cell envelope lipid 
profiles. PLoS One. 2011; 6:e23870. [PubMed: 21931620] 
Lamichhane G, Tyagi S, Bishai WR. Designer arrays for defined mutant analysis to detect genes 
essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect. Immun. 2005; 
73:2533–2540. [PubMed: 15784600] 
Lee SS, Mountain J, Koenig B, et al. The ethics of characterizing difference. guiding principles on 
using racial categories in human genetics. Genome Biol. 2008; 9(7):404. [PubMed: 18638359] 
Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological 
issues, and suggestions for research. Epidemiol. Rev. 2000; 22(2):187–202. [PubMed: 11218371] 
Long, ER.; Jablon, S. Veterans Administration Medical Monograph. Washington, DC.: Veternas 
Administration; 1955. Tuberculosis in the army of the United States in World War II: An 
Epidemiological Study with an Evaluation of X-ray Screening. 
Malik AN, Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on 
the presentation of disease. Lancet Infect. Dis. 2005; 5(3):174–183. [PubMed: 15766652] 
Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur. Respir 
J. 2005; 26(1):153–161. [PubMed: 15994402] 
Mitchison DA, Wallace JG, Bhatia AL, Selkon JB, Subbaiah TV, et al. A comparison of the virulence 
in guinea-pigs of South Indian and British tubercle bacilli. Tubercle. 1960; 41:1–22. [PubMed: 
14423002] 
Mountain JL, Risch N. Assessing genetic contributions to phenotypic differences among ‘racial’ and 
‘ethnic’ groups. Nat. Genet. 2004; 36(Suppl. 11):S48–S53. [PubMed: 15508003] 
Nahid P, Bliven EE, Kim EY, MacKenzie WR, Stout JE, et al. Influence of M. tuberculosis lineage 
variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010; 5(5):e10753. http://
dx.doi.org/10.1371/journal.pone.0010753. [PubMed: 20505778] 
Parwati I, Van CR, Van SD. Possible underlying mechanisms for successful emergence of the 
Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010; 10(2):103–111. 
[PubMed: 20113979] 
Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007; 
131(6):1817–1824. [PubMed: 17400690] 
Pasipanodya JG, McNabb SJ, Hilsenrath P, et al. Pulmonary impairment after tuberculosis and its 
contribution to TB burden. BMC Public Health. 2010; 10:259. [PubMed: 20482835] 
Pasipanodya J, Vecino E, Miller TL, et al. Non-Hispanic Whites have higher risk for pulmonary 
impairment from pulmonary tuberculosis. BMC Public Health. 2012a; 12(119)
Pasipanodya JG, Shashikant S, Gumbo T. Meta-analysis of clinical studies supports the 
pharmacokinetic variability hypothesis for acquired drug resistance and failure of anti-tuberculosis 
therapy. Clin. Infect. Dis. 2012b; 55(2):169–177. [PubMed: 22467670] 
Perez-Velez CM, Marais BJ. Tuberculosis in children. NEJM. 2012; 367(4):348–361. [PubMed: 
22830465] 
Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the 
Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS 
Pathog. 2011; 7:e1001307. [PubMed: 21408618] 
Risch N, Burchard E, Ziv E, Tang H. Categorization of humans in biomedical research: genes, race 
and disease. Genome Biol. 2002; 3(7) comment 2007. 
Rosenberg NA, Pritchard JK, Weber JL, et al. Genetic structure of human populations. Science. 2002; 
298(5602):2381–2385. [PubMed: 12493913] 
Shabbeer A, Cowan LS, Ozcaglar C, et al. TB-Lineage: an online tool for classification and analysis of 
strains of Mycobacterium tuberculosis complex. Infect. Genet. Evol. 2012; 12(4):789–797. 
[PubMed: 22406225] 
Stead WW. Variation in vulnerability to tuberculosis in America today: random, or legacies of 
different ancestral epidemics? Int. J. Tuberc. Lung Dis. 2001; 5(9):807–814. [PubMed: 11573891] 
Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by 
Mycobacterium tuberculosis. N. Engl. J. Med. 1990; 322(7):422–427. [PubMed: 2300105] 
Pasipanodya et al. Page 12













Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial 
interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. 
J. Clin. Microbiol. 2006; 44(12):4498–4510. [PubMed: 17005759] 
Tarrant County Public Health Department. Division of Tuberculosis Elimination, Tarrant County 
Public Health, Client Services. 2010
van Crevel R, Parwati I, Sahiratmadja E, et al. Infection with Mycobacterium tuberculosis Beijing 
genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients 
with tuberculosis. J. Infect. Dis. 2009; 200(11):1671–1674. [PubMed: 19863441] 
Vecino M, Pasipanodya JG, Slocum P, et al. Evidence for chronic lung impairment in patients treated 
for pulmonary tuberculosis. J. Infect. Public Health. 2011; 4(5–6):244–252. [PubMed: 22118719] 
Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug 
resistance and relapse in tuberculosis. N. Engl. J. Med. 1994; 330(17):1179–1184. [PubMed: 
8139628] 
World Health Organization. Global Tuberculosis Control: WHO, Report. Geneva, Switzerland: 2010. 
Zhivotovsky LA, Rosenberg NA, Feldman MW. Features of evolution and expansion of modern 
humans, inferred from genomewide microsatellite markers. Am. J. Hum. Genet. 2003; 72(5):
1171–1186. [PubMed: 12690579] 
Pasipanodya et al. Page 13














Panel A shows the comparison of the frequency of host–pathogen relationships across all 
levels of pulmonary impairment in treated patients. Panel B shows the comparison of the 
frequency of ancient versus modern Mycobacterium tuberculosis genotypes across all levels 
of pulmonary impairment.
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Table 3
Within lineage multivariate logistic regression analysis.
Variable Mycobacterium tuberculosis lineage
Euro-American (n = 182)
AOR (95% CI)
East-Asian (n = 72)
AOR (95% CI)
Indo-Oceanic (n = 51)
AOR (95% CI)
Host–pathogen relationships
Sympatric Referent Referent Referent
Allopatric 2.09 (1.06, 4.11)a 5.99 (1.48, 23.86)a 0.14 (0.02, 0.91)a
Smoking volume (pack-years)
<1 Referent Referent Referent
1–5 0.69 (0.25, 1.77) 0.28 (0.03, 3.09) 0.61 (0.07, 5.02)
6–15 2.13 (0.79, 5.73) 0.50 (0.12, 2.12) 0.78 (0.11, 5.56)
16–29 2.48 (0.73, 8.44) 0.26 (0.04, 1.81) 9.14 (0.43, 195.77)
>30 4.63 (1.56, 13.74)a 1.06 (0.17, 6.69) 0.70 (0.03, 16.28)
Age groups (years)
<30 Referent Referent Referent
30–39 1.22 (0.40, 3.74) 0.83 (0.11, 6.44) 0.11 (0.01, 1.21)
40–49 0.83 (0.29, 2.33) 0.29 (0.03, 3.12) 0.41 (0.03, 5.18)
50–59 1.85 (0.67, 5.11) 0.46 (0.06, 3.66) 0.18 (0.01, 2.42)
60–69 1.63 (0.47, 5.67) 0.72 (0.07, 7.10) 0.03 (0, 1.30)
>70 1.61 (0.44, 5.87) 0.33 (0.04, 2.60) 0.10 (0, 2.21)
AOR = Adjusted Odds Ratio.
a
Figures in italics denotes statistically significance, p < 0.05.






































































































































































































































































































Infect Genet Evol. Author manuscript; available in PMC 2015 September 25.
